Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.
Nome Bio has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Nome Bio's investors include Twelve Below, Refactor, Inflect Health.
Nome Bio is headquartered in San Diego, United States.
Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.
Nome Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nome Bio — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/nome-bio. Accessed August 14, 2026.
VCBacked. (2025). Nome Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/nome-bio
{{cite web |title=Nome Bio — Funding & Investors |url=https://www.vcbacked.co/company/nome-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated